Cigna Co. (NYSE:CI) Given Average Rating of “Moderate Buy” by Brokerages

Shares of Cigna Co. (NYSE:CIGet Rating) have been given an average rating of “Moderate Buy” by the twenty-three ratings firms that are currently covering the stock, MarketBeat reports. Seven analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $329.45.

A number of analysts have recently commented on the company. Raymond James cut Cigna from a “strong-buy” rating to an “outperform” rating and set a $370.00 price objective for the company. in a research report on Monday, November 21st. Cowen boosted their price target on Cigna from $329.00 to $385.00 in a research report on Monday, November 7th. Cowen upped their target price on Cigna from $329.00 to $385.00 in a report on Monday, November 7th. SVB Leerink upped their target price on Cigna from $305.00 to $335.00 and gave the company a “market perform” rating in a report on Tuesday, November 8th. Finally, Morgan Stanley upped their price target on Cigna from $347.00 to $365.00 and gave the company an “overweight” rating in a research note on Friday, January 6th.

Cigna Stock Down 2.1 %

NYSE:CI opened at $308.36 on Thursday. The company has a market cap of $94.28 billion, a price-to-earnings ratio of 14.73, a price-to-earnings-growth ratio of 1.13 and a beta of 0.69. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.62. Cigna has a twelve month low of $213.16 and a twelve month high of $340.11. The stock has a fifty day simple moving average of $321.69 and a 200-day simple moving average of $300.24.

Cigna (NYSE:CIGet Rating) last issued its quarterly earnings results on Thursday, November 3rd. The health services provider reported $6.04 earnings per share for the quarter, topping analysts’ consensus estimates of $5.70 by $0.34. Cigna had a return on equity of 15.94% and a net margin of 3.67%. The business had revenue of $45.36 billion for the quarter, compared to analyst estimates of $44.87 billion. Analysts anticipate that Cigna will post 23.13 EPS for the current year.

Cigna Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, December 21st. Shareholders of record on Tuesday, December 6th were paid a $1.12 dividend. The ex-dividend date was Monday, December 5th. This represents a $4.48 annualized dividend and a yield of 1.45%. Cigna’s payout ratio is currently 21.39%.

Insider Transactions at Cigna

In other Cigna news, insider Jason D. Sadler sold 16,667 shares of the business’s stock in a transaction dated Thursday, December 8th. The shares were sold at an average price of $333.88, for a total value of $5,564,777.96. Following the completion of the sale, the insider now owns 35,750 shares of the company’s stock, valued at approximately $11,936,210. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, EVP Cynthia Ryan sold 3,009 shares of the stock in a transaction on Friday, December 16th. The shares were sold at an average price of $327.95, for a total transaction of $986,801.55. Following the transaction, the executive vice president now directly owns 4,319 shares of the company’s stock, valued at $1,416,416.05. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Jason D. Sadler sold 16,667 shares of the stock in a transaction on Thursday, December 8th. The stock was sold at an average price of $333.88, for a total transaction of $5,564,777.96. Following the transaction, the insider now directly owns 35,750 shares in the company, valued at $11,936,210. The disclosure for this sale can be found here. 0.80% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Householder Group Estate & Retirement Specialist LLC bought a new position in shares of Cigna during the third quarter valued at about $34,000. RFG Advisory LLC increased its holdings in Cigna by 13.0% during the second quarter. RFG Advisory LLC now owns 1,697 shares of the health services provider’s stock worth $478,000 after buying an additional 195 shares during the last quarter. American Research & Management Co. increased its stake in shares of Cigna by 1,875.0% in the second quarter. American Research & Management Co. now owns 158 shares of the health services provider’s stock worth $42,000 after purchasing an additional 150 shares in the last quarter. Creative Planning increased its stake in shares of Cigna by 3.7% in the second quarter. Creative Planning now owns 33,692 shares of the health services provider’s stock worth $8,879,000 after purchasing an additional 1,196 shares in the last quarter. Finally, Exane Derivatives increased its stake in shares of Cigna by 127.8% in the second quarter. Exane Derivatives now owns 287 shares of the health services provider’s stock worth $76,000 after purchasing an additional 161 shares in the last quarter. 87.61% of the stock is owned by institutional investors.

About Cigna

(Get Rating)

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers.

Further Reading

Analyst Recommendations for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.